Delivery Order SPE2DP20D0002-SPE2DP23F2294
Award Date 2/22/23
Potential Completion Date 2/28/23
Potential Value $305K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals USA, Inc. a $293,647.86 firm fixed price delivery order contract to provide adenovirus type 4 from its Parsippany, New Jersey facility. The contract has a period of performance starting on May 17, 2022 and ending on May 24, 2022. Teva Pharmaceuticals USA, Inc. will serve as the prime contractor to supply adenovirus type 4 to the Defense Logistics Agency Troop Support Medical.</p>
- The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals USA, Inc. a $587,295.72 firm fixed price delivery order contract to provide adenovirus type 4 from April 19, 2022 through April 26, 2022. The place of performance for this contract is Parsippany, New Jersey. Teva Pharmaceuticals USA, Inc. will serve as the prime contractor to supply adenovirus type 4 to the Defense Logistics Agency Troop Support Medical. No applicable subcontractors were identified.
- The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals USA, Inc. a $305,393.76 firm fixed price delivery order contract to provide Adenovirus Type 4 from February 22, 2023 through February 28, 2023. The place of performance will be Teva Pharmaceuticals' facility located in Parsippany, New Jersey. Teva Pharmaceuticals will serve as the prime contractor to supply the Adenovirus Type 4 to the Defense Logistics Agency Troop Support Medical. No subcontractors were...
- The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $293,647.86 firm fixed price delivery order contract to provide Adenovirus Type 4. The place of performance for this January 18, 2022 through January 25, 2022 contract is Parsippany, New Jersey. Teva Pharmaceuticals USA, Inc. will serve as the prime contractor to supply the Adenovirus Type 4 to the Defense Logistics Agency Troop Support Medical, with all work taking place in Parsippany, New Jersey under...
- The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals Usa, Inc. a $458,090.64 firm fixed price delivery order contract to provide adenovirus type 4 with a period of performance from March 22, 2023 through March 28, 2023 at the place of performance location of Parsippany, New Jersey 07054. Teva Pharmaceuticals Usa, Inc. will serve as the prime contractor to supply adenovirus type 4 to the Defense Logistics Agency Troop Support Medical as the funding agency....
- The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $610,787.52 firm fixed price delivery order contract to provide Adenovirus Type 4. The place of performance for this contract is Parsippany, New Jersey, and the period of performance is from July 18, 2023 through July 25, 2023. Teva Pharmaceuticals USA, Inc. will serve as the prime contractor to supply Adenovirus Type 4 to the Defense Logistics Agency Troop Support Medical. No subcontractors were...
- <p>The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals USA, Inc. a $282,353.76 firm fixed price delivery order contract to provide adenovirus type 4. The prime contractor, Teva Pharmaceuticals USA, Inc., will perform the work in Parsippany, New Jersey from December 7, 2021 through December 14, 2021.</p>
- The Defense Logistics Agency Troop Support Medical awarded a $305,393.76 firm fixed price delivery order to Teva Pharmaceuticals USA, Inc. of Parsippany, New Jersey. Under this contract, Teva will provide adenovirus type 4 to the agency. The contract has a period of performance starting on August 22, 2023 through August 29, 2023. As the Defense Logistics Agency supports the medical needs of the Department of Defense, this delivery order was likely placed to supply necessary pharmaceuticals for...
- <p>The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals USA, Inc. a $458,090.64 firm fixed price delivery order contract to provide adenovirus type 4 with a period of performance starting on January 18, 2023 through January 24, 2023. The place of performance will be Teva Pharmaceuticals' location in Parsippany, New Jersey. No subcontractors were identified.</p>
- The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $610,787.52 firm fixed price delivery order contract to provide adenovirus type 4 with a period of performance from July 18, 2023 through July 25, 2023 at the place of performance in Parsippany, New Jersey. Teva Pharmaceuticals USA, Inc. will serve as the prime contractor to supply adenovirus type 4 to the Defense Logistics Agency Troop Support Medical under this contract award. No applicable...